Measuring Legacy Dosage For Patients With Co-Occurring Disorders: The Ten-C Expectation Findings

Abstract

Legacy Intervention (LI) has been shown to be helpful for the patients with co-occurring disorders by alleviating life concerns such as social isolation, discrimination and financial worries. However, legacy dosage has not been concretely measured. The purpose of this study is to illustrate how to use a clinical measure in a LI project to highlight individualized legacy dosage throughout the treatment process in a partial hospital program. This measure aims to empower patients to appreciate life-stress management for treatment success. Among 37 patients in LI treatment, legacy dosage is measured by patients’ exposure to positive support concretely marked on an 11-point individualized self-anchored scale after each session. These patients connected the points on a graph with their reported exploration after describing their expectations. Legacy is defined by the patients as reported as a memorable set of past coping successes to explicitly share with others. Due to its individualized nature, a composite case from these cases is used to illustrate how legacy dosage is measured to provide a place for patients to disclose their treatment expectations.